- Home
- SILO vs CPHI Comparison
SILO vs CPHI Comparison
Compare SILO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SILO
- CPHI
- Stock Information
- Founded
- SILO 2010
- CPHI N/A
- Country
- SILO United States
- CPHI China
- Employees
- SILO N/A
- CPHI 239
- Industry
- SILO Apparel
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- SILO Consumer Discretionary
- CPHI Health Care
- Exchange
- SILO Nasdaq
- CPHI Nasdaq
- Market Cap
- SILO 4.7M
- CPHI 4.0M
- IPO Year
- SILO N/A
- CPHI N/A
- Fundamental
- Price
- SILO $1.96
- CPHI $0.21
- Analyst Decision
- SILO
- CPHI
- Analyst Count
- SILO 0
- CPHI 0
- Target Price
- SILO N/A
- CPHI N/A
- AVG Volume (30 Days)
- SILO 9.0M
- CPHI 1.9M
- Earning Date
- SILO 02-14-2025
- CPHI 11-13-2024
- Dividend Yield
- SILO N/A
- CPHI N/A
- EPS Growth
- SILO N/A
- CPHI N/A
- EPS
- SILO N/A
- CPHI N/A
- Revenue
- SILO $72,102.00
- CPHI $5,544,620.00
- Revenue This Year
- SILO $1.86
- CPHI N/A
- Revenue Next Year
- SILO N/A
- CPHI N/A
- P/E Ratio
- SILO N/A
- CPHI N/A
- Revenue Growth
- SILO N/A
- CPHI N/A
- 52 Week Low
- SILO $0.77
- CPHI $0.13
- 52 Week High
- SILO $4.50
- CPHI $0.60
- Technical
- Relative Strength Index (RSI)
- SILO 79.84
- CPHI 49.71
- Support Level
- SILO $1.62
- CPHI $0.19
- Resistance Level
- SILO $2.16
- CPHI $0.24
- Average True Range (ATR)
- SILO 0.31
- CPHI 0.04
- MACD
- SILO 0.10
- CPHI -0.00
- Stochastic Oscillator
- SILO 43.37
- CPHI 23.53
About SILO Silo Pharma Inc.
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.